Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

BioLineRx Announces Notice of Allowance from USPTO for Motixafortide, Anti-PD-1 Combination

americanpharmaceuticalreviewMarch 05, 2020

Tag: BioLineRx , Motixafortide , PD-1

PharmaSources Customer Service